Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer

SIMPLE SUMMARY: Incidence and death rates for endometrial cancer are steadily rising world-wide. Endometrial cancer patients at high risk for recurrence are treated with chemotherapy, which causes significant toxicity. Molecularly targeted drugs have been found to cause less toxicity than chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Vishal, Rai, Rajani, Benbrook, Doris Mangiaracina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150795/
https://www.ncbi.nlm.nih.gov/pubmed/34066052
http://dx.doi.org/10.3390/cancers13102322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150795/
https://www.ncbi.nlm.nih.gov/pubmed/34066052
http://dx.doi.org/10.3390/cancers13102322

Ejemplares similares